Inclusion of pregnant women in COVID-19 vaccine development

  • Lancet Infect Dis. 2020 Sep;20(9):1007-1008. doi: 10.1016/S1473-3099(20)30638-1.
Paul T Heath  1 ,  Kirsty Le Doare  2 ,  Asma Khalil  3
Affiliations
  • 1. Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London SW17 0RE, UK. Electronic address: [email protected].
  • 2. Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London SW17 0RE, UK; Medical Research Council/Uganda Virus Research Institute at London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • 3. Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London SW17 0RE, UK; Fetal Medicine Unit, St George's Hospital, London, UK.
PMID: 32795409 DOI: 10.1016/S1473-3099(20)30638-1
Products